Big Pharma continues with layoffs...this time not sales...BD
The drugmaker is scaling back at sites in Indianapolis that make active pharmaceutical ingredients for the Humalog and Humulin insulin meds, as well as for the Forteo osteoporosis treatment. UPDATE: A Lilly spokesman tells us that 430 of the jobs will come from manufacturing, no sites are being closed and API production isn’t being shifted elsewhere. The drugmaker employs about 12,000 people in Indianapolis.
Pharmalot » Lilly Is Laying Off 500 Manufacturing, R&D Workers
0 comments :
Post a Comment